Akanda logo

Akanda(NASDAQ) AKAN

Market Cap$3.50MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-100%
5 YearN/A
1 Year-97%
1 Month-55%
$1.34
-3.26%
-0.05Today
After hours$1.35+$0.02 (+1.12%)
Akanda last closing stock price
MetricPriceDate
Last closeUSD 1.382026-10-13
Akanda stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-26.98%USD 1.892026-10-06
1 month-55.05%USD 3.072026-09-11
3 month-86.2%USD 10.002026-07-15
Year to date-86.59%USD 10.292025-12-31
1 year-97.22%USD 49.732025-10-13
3 year-99.96%USD 3,147.752023-10-13
Since inception-100%USD 590,624.262022-03-15

Akanda Financials at a Glance

Market Cap

$3.50MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.02M

Net Income (TTM)

-$53.18M

EPS (TTM)

-$110.84

P/E Ratio

-0.01

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.34

Volume

103,535.083

Open

$1.42

Previous Close

$1.33

Daily Range

$1.32 - $1.42

52-Week Range

$1.32 - $78.90

Estimated Earnings Date

Apr 29, 2026

AKAN News

GettyImages-1294843884

Why Akanda Stock Blasted Nearly 14% Higher Today

Eric VolkmanMar 21, 2022

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Akanda

Akanda Corp. is a cannabis-focused company engaged in the cultivation, production, and distribution of cannabis products for medical and wellness purposes. Operating through various subsidiaries, Akanda has a presence in the United Kingdom, Lesotho, and other global regions, aiming to meet the growing demand for cannabis-derived items.

Products and Services
  • Cultivation and production of cannabis products
  • Distribution of medical and wellness cannabis items
  • Global operations with a focus on emerging markets
Growth Outlook
  • Significant market potential in the global cannabis industry
  • Expansion plans targeting new regions and demographics
  • Increased consumer demand for medical cannabis products
Financial Highlights
  • Recent quarterly revenue of $258,075, showing potential for growth
  • Trailing twelve months (TTM) revenue of $762,608, indicating upward momentum
  • Cash and cash equivalents of $503,562 as of the latest quarter
Akanda Corp. operates in a rapidly evolving industry with substantial growth potential. The company's focus on medical and wellness cannabis products positions it well to capitalize on increasing consumer demand. Recent financial data indicates a revenue trajectory that, while currently modest, suggests opportunities for expansion and increased market share. The company's strategic initiatives and global presence may further enhance its ability to navigate the competitive landscape of the cannabis sector. Investors may find Akanda Corp. an intriguing option as the company continues to develop its operations and explore new markets.
AI Generated • Sep 19, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

8

CEO

Katharyn M. Field, MBA

Website

www.akandacorp.com

Headquarters

Toronto, ON M5X 1G5, CA

AKAN Financials

Key Financial Metrics (TTM)

Gross Margin

-234.12%

Operating Margin

-1290.25%

Net Income Margin

-7691.50%

Return on Equity

391.92%

Return on Capital

-144.39%

Return on Assets

-791.92%

Earnings Yield

-100.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.50MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.63M

Volume

103.54K

Avg. Volume

1.34M

Financials (TTM)

Gross Profit

-$1.29M

Operating Income

-$12.07M

EBITDA

-$10.38M

Operating Cash Flow

-$11.31M

Capital Expenditure

-$3.26M

Free Cash Flow

-$14.57M

Cash & ST Invst.

$755.24K

Total Debt

$18.57M

Akanda Performance Analysis

Akanda annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,619,6826223.0%
20232023-12-31USD 423,683-83.8%
20242024-12-31USD 0N/A
20252025-12-31USD 258,075N/A
Akanda sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-24.6%
Q22025-06-30-100.0%
Q42025-12-31N/A
Q22026-06-3056.7%
Akanda annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -21,909.3838.4%
20232023-12-31USD -40,296.5483.9%
20242024-12-31USD -276.40-99.3%
20252025-12-31USD -669.96142.4%
Akanda sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3186.1%
Q22025-06-3016.2%
Q42025-12-31-1488.6%
Q22026-06-3098.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$404.39K

-15.2%

Gross Profit

-$647.23K

-364.8%

Gross Margin

-1.60%

N/A

Market Cap

$3.50MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$437.74K

N/A

Employees

8

N/A

Net Income

-$6.20M

-131.0%

EBITDA

-$4.61M

-126.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$755.24K

-87.4%

Total Debt

$18.57M

+4859.9%

Accounts Receivable

$1.66M

+431.0%

Inventory

$0.00

N/A

Long Term Debt

$10.43M

N/A

Short Term Debt

$8.15M

+2075.5%

Return on Assets

-7.92%

N/A

Return on Invested Capital

1.41%

N/A

Free Cash Flow

-$4.46M

-13.4%

Operating Cash Flow

-$3.19M

-23.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
UPCUniverse Pharmaceuticals Inc.
$4.15-2.81%
JAGXJaguar Health, Inc.
$4.18+0.48%
RDHLRedHill Biopharma Ltd.
$0.49-5.59%
GNPXGenprex, Inc.
$2.33-7.17%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$221.30-3.16%
BACBank of America
$51.39-4.76%
CRWVCoreWeave
$65.78-15.46%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$110.54-13.35%

Questions About AKAN

What is the current price of Akanda?

Akanda is trading at $1.33 per share.

What is the 52-week range for Akanda?

Over the past 52 weeks, Akanda has traded between $1.32 and $78.90.

How much debt does Akanda have?

As of the most recent reporting period, Akanda reported total debt of $14.24M.

How much cash does Akanda have on hand?

Akanda reported $504.14K in cash and cash equivalents in its most recent financial results.

What is Akanda’s dividend yield?

Akanda does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services